{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:24:33Z","timestamp":1790735073514,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Union\u2019s Horizon 2020 Research and Innovation Program","award":["grant agreement No. 952455"],"award-info":[{"award-number":["grant agreement No. 952455"]}]},{"name":"European Union\u2019s Horizon 2020 Research and Innovation Program","award":["grant agreement No. 952455"],"award-info":[{"award-number":["grant agreement No. 952455"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gangliogliomas (GGs) are low-grade brain tumours that cause intractable focal epilepsy in children and adults. In GG, as in epileptogenic focal malformations (<jats:italic>i.e.,<\/jats:italic>tuberous sclerosis complex, TSC), there is evidence of sustained neuroinflammation with involvement of the pro-inflammatory cytokine IL-1\u03b2. On the other hand, anti-inflammatory mediators are less studied but bear relevance for understanding seizure mechanisms. Therefore, we investigated the effect of the key anti-inflammatory cytokine IL-10 on GABAergic neurotransmission in GG. We assessed the IL-10 dependent signaling by transcriptomic analysis, immunohistochemistry and performed voltage-clamp recordings on<jats:italic>Xenopus<\/jats:italic>oocytes microtransplanted with cell membranes from brain specimens, to overcome the limited availability of acute\u00a0GG slices. We report that IL-10-related mRNAs were up-regulated in GG and slightly in TSC. Moreover, we found IL-10 receptors are expressed by neurons and astroglia. Furthermore, GABA currents were potentiated significantly by IL-10 in GG. This effect was time and dose-dependent and inhibited by blockade of IL-10 signaling. Notably, in the same tissue, IL-1\u03b2 reduced GABA current amplitude and prevented the IL-10 effect. These results suggest that in epileptogenic tissue, pro-inflammatory mechanisms of hyperexcitability prevail over key anti-inflammatory pathways enhancing GABAergic inhibition. Hence, boosting the effects of specific anti-inflammatory molecules could resolve inflammation and reduce intractable seizures.<\/jats:p>","DOI":"10.1038\/s41598-022-22806-9","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T13:09:20Z","timestamp":1666789760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["GABAA receptor function is enhanced by Interleukin-10 in human epileptogenic gangliogliomas and its effect is counteracted by Interleukin-1\u03b2"],"prefix":"10.1038","volume":"12","author":[{"given":"Gabriele","family":"Ruffolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Alfano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Romagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierangelo","family":"Cifelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gaeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Morano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Anink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"M\u00fchlebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Vezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Aronica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"22806_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40478-020-00904-x","volume":"8","author":"RJ Slegers","year":"2020","unstructured":"Slegers, R. J. & Blumcke, I. Low-grade developmental and epilepsy associated brain tumors: A critical update 2020. Acta Neuropathol. Commun. 8, 27 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"22806_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.seizure.2016.12.012","volume":"44","author":"\u00d6 Ert\u00fcrk \u00c7etin","year":"2017","unstructured":"Ert\u00fcrk \u00c7etin, \u00d6., \u0130\u015fler, C., Uzan, M. & \u00d6zkara, \u00c7. Epilepsy-related brain tumors. Seizure 44, 93\u201397 (2017).","journal-title":"Seizure"},{"key":"22806_CR3","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/s41591-018-0172-x","volume":"24","author":"HY Koh","year":"2018","unstructured":"Koh, H. Y. et al. BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors. Nat. Med. 24, 1662\u20131668 (2018).","journal-title":"Nat. Med."},{"key":"22806_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.neuroscience.2007.10.036","volume":"151","author":"E Aronica","year":"2008","unstructured":"Aronica, E. et al. Gene expression profile analysis of epilepsy-associated gangliogliomas. Neuroscience 151, 272\u2013292 (2008).","journal-title":"Neuroscience"},{"key":"22806_CR5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1474-4422(21)00265-9","volume":"20","author":"I Blumcke","year":"2021","unstructured":"Blumcke, I. et al. Neocortical development and epilepsy: Insights from focal cortical dysplasia and brain tumours. Lancet Neurol. 20, 943\u2013955 (2021).","journal-title":"Lancet Neurol."},{"key":"22806_CR6","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1152\/jn.00523.2019","volume":"123","author":"RU Goz","year":"2020","unstructured":"Goz, R. U., Akg\u00fcl, G. & LoTurco, J. J. BRAFV600E expression in neural progenitors results in a hyperexcitable phenotype in neocortical pyramidal neurons. J. Neurophysiol. 123, 2449\u20132464 (2020).","journal-title":"J. Neurophysiol."},{"key":"22806_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/bpa.12081","volume":"24","author":"AS Prabowo","year":"2014","unstructured":"Prabowo, A. S. et al. BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors. Brain Pathol. 24, 52\u201366 (2014).","journal-title":"Brain Pathol."},{"key":"22806_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab268","author":"S Cases-Cunillera","year":"2021","unstructured":"Cases-Cunillera, S. et al. Heterogeneity and excitability of BRAF V600E-induced tumors is determined by Akt\/mTOR-signaling state and Trp53-loss. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noab268 (2021).","journal-title":"Neuro Oncol."},{"key":"22806_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12974-015-0315-7","volume":"12","author":"AS Prabowo","year":"2015","unstructured":"Prabowo, A. S. et al. Differential expression and clinical significance of three inflammation-related microRNAs in gangliogliomas. J. Neuroinflammation 12, 97 (2015).","journal-title":"J. Neuroinflammation"},{"key":"22806_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","volume":"15","author":"A Vezzani","year":"2019","unstructured":"Vezzani, A., Balosso, S. & Ravizza, T. Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat. Rev. Neurol. 15, 459\u2013472 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"22806_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neubiorev.2016.02.007","volume":"63","author":"EE de Vries","year":"2016","unstructured":"de Vries, E. E. et al. Inflammatory mediators in human epilepsy: A systematic review and meta-analysis. Neurosci. Biobehav. Rev. 63, 177\u2013190 (2016).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"22806_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","volume":"244","author":"A Vezzani","year":"2013","unstructured":"Vezzani, A., Aronica, E., Mazarati, A. & Pittman, Q. J. Epilepsy and brain inflammation. Exp. Neurol. 244, 11\u201321 (2013).","journal-title":"Exp. Neurol."},{"key":"22806_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","volume":"96","author":"A Vezzani","year":"2015","unstructured":"Vezzani, A. & Viviani, B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology 96, 70\u201382 (2015).","journal-title":"Neuropharmacology"},{"key":"22806_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s13311-011-0039-z","volume":"8","author":"M Maroso","year":"2011","unstructured":"Maroso, M. et al. Interleukin-1\u03b2 biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 8, 304\u2013315 (2011).","journal-title":"Neurotherapeutics"},{"key":"22806_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.nbd.2013.07.015","volume":"59","author":"FM Noe","year":"2013","unstructured":"Noe, F. M. et al. Pharmacological blockade of IL-1\u03b2\/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy. Neurobiol. Dis. 59, 183\u2013193 (2013).","journal-title":"Neurobiol. Dis."},{"key":"22806_CR16","doi-asserted-by":"publisher","first-page":"7822","DOI":"10.1007\/s12035-018-0946-7","volume":"55","author":"P Ambrogini","year":"2018","unstructured":"Ambrogini, P. et al. Neurobiological correlates of alpha-tocopherol antiepileptogenic effects and MicroRNA expression modulation in a rat model of kainate-induced seizures. Mol. Neurobiol. 55, 7822\u20137838 (2018).","journal-title":"Mol. Neurobiol."},{"key":"22806_CR17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S1474-4422(22)00213-7","volume":"21","author":"P Curatolo","year":"2022","unstructured":"Curatolo, P., Specchio, N. & Aronica, E. Advances in the genetics and neuropathology of tuberous sclerosis complex: Edging closer to targeted therapy. Lancet Neurol. 21, 843\u2013856 (2022).","journal-title":"Lancet Neurol."},{"key":"22806_CR18","doi-asserted-by":"publisher","first-page":"E1017","DOI":"10.3390\/biom10071017","volume":"10","author":"C Porro","year":"2020","unstructured":"Porro, C., Cianciulli, A. & Panaro, M. A. The regulatory role of IL-10 in neurodegenerative diseases. Biomolecules 10, E1017 (2020).","journal-title":"Biomolecules"},{"key":"22806_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","volume":"10","author":"M Saraiva","year":"2010","unstructured":"Saraiva, M. & O\u2019Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170\u2013181 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"22806_CR20","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1093\/brain\/awy276","volume":"141","author":"M Morin-Brureau","year":"2018","unstructured":"Morin-Brureau, M. et al. Microglial phenotypes in the human epileptic temporal lobe. Brain 141, 3343\u20133360 (2018).","journal-title":"Brain"},{"key":"22806_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12974-019-1452-1","volume":"16","author":"Y Sun","year":"2019","unstructured":"Sun, Y. et al. Interleukin-10 inhibits interleukin-1\u03b2 production and inflammasome activation of microglia in epileptic seizures. J. Neuroinflammation 16, 66 (2019).","journal-title":"J. Neuroinflammation"},{"key":"22806_CR22","doi-asserted-by":"publisher","DOI":"10.1159\/000521710","author":"Y-P Zhang","year":"2022","unstructured":"Zhang, Y.-P. et al. Interleukin-10 attenuates behavioral, immune and neurotrophin changes induced by chronic central administration of interleukin-1\u03b2 in rats. NeuroImmunoModulation https:\/\/doi.org\/10.1159\/000521710 (2022).","journal-title":"NeuroImmunoModulation"},{"key":"22806_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.nbd.2015.07.003","volume":"82","author":"C Roseti","year":"2015","unstructured":"Roseti, C. et al. GABAA currents are decreased by IL-1\u03b2 in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis. Neurobiol. Dis. 82, 311\u2013320 (2015).","journal-title":"Neurobiol. Dis."},{"key":"22806_CR24","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1523\/JNEUROSCI.4486-04.2005","volume":"25","author":"D Stellwagen","year":"2005","unstructured":"Stellwagen, D., Beattie, E. C., Seo, J. Y. & Malenka, R. C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J. Neurosci. 25, 3219\u20133228 (2005).","journal-title":"J. Neurosci."},{"key":"22806_CR25","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1111\/epi.12354","volume":"54","author":"C Roseti","year":"2013","unstructured":"Roseti, C. et al. Fractalkine\/CX3CL1 modulates GABAA currents in human temporal lobe epilepsy. Epilepsia 54, 1834\u20131844 (2013).","journal-title":"Epilepsia"},{"key":"22806_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00540-008-0639-x","volume":"22","author":"J Oto","year":"2008","unstructured":"Oto, J. et al. Plasma proinflammatory and anti-inflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients. J. Anesth. 22, 207\u2013212 (2008).","journal-title":"J. Anesth."},{"key":"22806_CR27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O\u2019Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683\u2013765 (2001).","journal-title":"Annu. Rev. Immunol."},{"key":"22806_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.nbd.2006.06.003","volume":"24","author":"T Ravizza","year":"2006","unstructured":"Ravizza, T. et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol. Dis. 24, 128\u2013143 (2006).","journal-title":"Neurobiol. Dis."},{"key":"22806_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1124\/jpet.117.244673","volume":"364","author":"S-H Chuang","year":"2018","unstructured":"Chuang, S.-H. & Reddy, D. S. Genetic and molecular regulation of extrasynaptic GABA-A receptors in the brain: Therapeutic insights for epilepsy. J. Pharmacol. Exp. Ther. 364, 180\u2013197 (2018).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"22806_CR30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/01.wnr.0000208997.23448.ea","volume":"17","author":"M Tamura","year":"2006","unstructured":"Tamura, M., Koyama, R., Ikegaya, Y., Matsuki, N. & Yamada, M. K. K252a, an inhibitor of Trk, disturbs pathfinding of hippocampal mossy fibers. NeuroReport 17, 481\u2013486 (2006).","journal-title":"NeuroReport"},{"key":"22806_CR31","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.phrs.2016.07.038","volume":"111","author":"R Roskoski","year":"2016","unstructured":"Roskoski, R. Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases. Pharmacol. Res. 111, 784\u2013803 (2016).","journal-title":"Pharmacol. Res."},{"key":"22806_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1196\/annals.1391.022","volume":"1113","author":"T Bartfai","year":"2007","unstructured":"Bartfai, T. et al. Interleukin-1 system in CNS stress: Seizures, fever, and neurotrauma. Ann. N. Y. Acad. Sci. 1113, 173\u2013177 (2007).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"22806_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1528-1167.2007.01270.x","volume":"49","author":"M Wong","year":"2008","unstructured":"Wong, M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 49, 8\u201321 (2008).","journal-title":"Epilepsia"},{"key":"22806_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1742-2094-10-12","volume":"10","author":"AS Prabowo","year":"2013","unstructured":"Prabowo, A. S. et al. Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions. J. Neuroinflammation 10, 12 (2013).","journal-title":"J. Neuroinflammation"},{"key":"22806_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nbd.2015.04.016","volume":"80","author":"B Zhang","year":"2015","unstructured":"Zhang, B., Zou, J., Rensing, N. R., Yang, M. & Wong, M. Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex. Neurobiol. Dis. 80, 70\u201379 (2015).","journal-title":"Neurobiol. Dis."},{"key":"22806_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1684\/epd.2021.1253","volume":"23","author":"N Specchio","year":"2021","unstructured":"Specchio, N. et al. Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: Who, when, and what. Epileptic Disord. 23, 53\u201373 (2021).","journal-title":"Epileptic Disord."},{"key":"22806_CR37","doi-asserted-by":"publisher","first-page":"101433","DOI":"10.1016\/j.isci.2020.101433","volume":"23","author":"TC Chamberlain","year":"2020","unstructured":"Chamberlain, T. C. et al. Interleukin-10 and small molecule SHIP1 allosteric regulators trigger anti-inflammatory effects through SHIP1\/STAT3 complexes. iScience 23, 101433 (2020).","journal-title":"iScience"},{"key":"22806_CR38","doi-asserted-by":"publisher","first-page":"104612","DOI":"10.1016\/j.nbd.2019.104612","volume":"134","author":"JD Mills","year":"2020","unstructured":"Mills, J. D. et al. Coding and non-coding transcriptome of mesial temporal lobe epilepsy: Critical role of small non-coding RNAs. Neurobiol. Dis. 134, 104612 (2020).","journal-title":"Neurobiol. Dis."},{"key":"22806_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nbd.2016.07.014","volume":"95","author":"G Ruffolo","year":"2016","unstructured":"Ruffolo, G. et al. Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions. Neurobiol. Dis. 95, 93\u2013101 (2016).","journal-title":"Neurobiol. Dis."},{"key":"22806_CR40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/nan.12522","volume":"45","author":"I Bl\u00fcmcke","year":"2019","unstructured":"Bl\u00fcmcke, I. et al. Review: Challenges in the histopathological classification of ganglioglioma and DNT: Microscopic agreement studies and a preliminary genotype-phenotype analysis. Neuropathol. Appl. Neurobiol. 45, 95\u2013107 (2019).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"22806_CR41","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1073\/pnas.0438006100","volume":"100","author":"E Palma","year":"2003","unstructured":"Palma, E. et al. Microtransplantation of membranes from cultured cells to Xenopus oocytes: a method to study neurotransmitter receptors embedded in native lipids. Proc. Natl. Acad. Sci. U.S.A. 100, 2896\u20132900 (2003).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"22806_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuropharm.2016.03.027","volume":"107","author":"A Suryanarayanan","year":"2016","unstructured":"Suryanarayanan, A. et al. Role of interleukin-10 (IL-10) in regulation of GABAergic transmission and acute response to ethanol. Neuropharmacology 107, 181\u2013188 (2016).","journal-title":"Neuropharmacology"},{"key":"22806_CR43","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/2661","volume":"4","author":"AR Brooks-Kayal","year":"1998","unstructured":"Brooks-Kayal, A. R., Shumate, M. D., Jin, H., Rikhter, T. Y. & Coulter, D. A. Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat. Med. 4, 1166\u20131172 (1998).","journal-title":"Nat. Med."},{"key":"22806_CR44","doi-asserted-by":"publisher","first-page":"10183","DOI":"10.1073\/pnas.0403683101","volume":"101","author":"E Palma","year":"2004","unstructured":"Palma, E. et al. Phosphatase inhibitors remove the run-down of gamma-aminobutyric acid type A receptors in the human epileptic brain. Proc. Natl. Acad. Sci. U.S.A. 101, 10183\u201310188 (2004).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"22806_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrn1625","volume":"6","author":"M Farrant","year":"2005","unstructured":"Farrant, M. & Nusser, Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat. Rev. Neurosci. 6, 215\u2013229 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"22806_CR46","doi-asserted-by":"publisher","first-page":"38856","DOI":"10.1074\/jbc.M004910200","volume":"275","author":"NJ Brandon","year":"2000","unstructured":"Brandon, N. J. et al. GABAA receptor phosphorylation and functional modulation in cortical neurons by a protein kinase C-dependent pathway. J. Biol. Chem. 275, 38856\u201338862 (2000).","journal-title":"J. Biol. Chem."},{"key":"22806_CR47","doi-asserted-by":"publisher","first-page":"15219","DOI":"10.1073\/pnas.0507339102","volume":"102","author":"D Ragozzino","year":"2005","unstructured":"Ragozzino, D. et al. Rundown of GABA type A receptors is a dysfunction associated with human drug-resistant mesial temporal lobe epilepsy. Proc. Natl. Acad. Sci. U.S.A. 102, 15219\u201315223 (2005).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"22806_CR48","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1111\/j.1528-1167.2007.01131.x","volume":"48","author":"E Palma","year":"2007","unstructured":"Palma, E. et al. The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation. Epilepsia 48, 1842\u20131849 (2007).","journal-title":"Epilepsia"},{"key":"22806_CR49","doi-asserted-by":"publisher","first-page":"614923","DOI":"10.3389\/fneur.2020.614923","volume":"11","author":"J M\u00fcller","year":"2020","unstructured":"M\u00fcller, J. et al. Astrocytic GABA accumulation in experimental temporal lobe epilepsy. Front Neurol 11, 614923 (2020).","journal-title":"Front Neurol"},{"key":"22806_CR50","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/j.1528-1167.2011.03111.x","volume":"52","author":"L Conti","year":"2011","unstructured":"Conti, L. et al. Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex. Epilepsia 52, 1635\u20131644 (2011).","journal-title":"Epilepsia"},{"key":"22806_CR51","doi-asserted-by":"publisher","first-page":"244ra89","DOI":"10.1126\/scitranslmed.3008065","volume":"6","author":"J Pallud","year":"2014","unstructured":"Pallud, J. et al. Cortical GABAergic excitation contributes to epileptic activities around human glioma. Sci Transl Med 6, 244ra89 (2014).","journal-title":"Sci Transl Med"},{"key":"22806_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.eplepsyres.2004.04.007","volume":"59","author":"J Hulkkonen","year":"2004","unstructured":"Hulkkonen, J. et al. The balance of inhibitory and excitatory cytokines is differently regulated in vivo and in vitro among therapy resistant epilepsy patients. Epilepsy Res. 59, 199\u2013205 (2004).","journal-title":"Epilepsy Res."},{"key":"22806_CR53","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/epi.13750","volume":"58","author":"WB Gallentine","year":"2017","unstructured":"Gallentine, W. B. et al. Plasma cytokines associated with febrile status epilepticus in children: A potential biomarker for acute hippocampal injury. Epilepsia 58, 1102\u20131111 (2017).","journal-title":"Epilepsia"},{"key":"22806_CR54","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12883-020-01825-x","volume":"20","author":"P Basnyat","year":"2020","unstructured":"Basnyat, P. et al. Chronically reduced IL-10 plasma levels are associated with hippocampal sclerosis in temporal lobe epilepsy patients. BMC Neurol. 20, 241 (2020).","journal-title":"BMC Neurol."},{"key":"22806_CR55","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12974-017-0974-7","volume":"14","author":"K Kim","year":"2017","unstructured":"Kim, K. et al. Analysis of plasma multiplex cytokines and increased level of IL-10 and IL-1Ra cytokines in febrile seizures. J. Neuroinflammation 14, 200 (2017).","journal-title":"J. Neuroinflammation"},{"key":"22806_CR56","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/ana.24806","volume":"80","author":"DL Kenney-Jung","year":"2016","unstructured":"Kenney-Jung, D. L. et al. Febrile infection-related epilepsy syndrome treated with anakinra. Ann. Neurol. 80, 939\u2013945 (2016).","journal-title":"Ann. Neurol."},{"key":"22806_CR57","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/acn3.51229","volume":"7","author":"Y-C Lai","year":"2020","unstructured":"Lai, Y.-C. et al. Anakinra usage in febrile infection related epilepsy syndrome: an international cohort. Ann. Clin. Transl. Neurol. 7, 2467\u20132474 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"22806_CR58","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro Oncol. 23, 1231\u20131251 (2021).","journal-title":"Neuro Oncol."},{"key":"22806_CR59","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","volume":"123","author":"H Northrup","year":"2021","unstructured":"Northrup, H. et al. Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr. Neurol. 123, 50\u201366 (2021).","journal-title":"Pediatr. Neurol."},{"key":"22806_CR60","doi-asserted-by":"publisher","first-page":"15078","DOI":"10.1073\/pnas.232574499","volume":"99","author":"E Palma","year":"2002","unstructured":"Palma, E. et al. Expression of human epileptic temporal lobe neurotransmitter receptors in Xenopus oocytes: An innovative approach to study epilepsy. Proc. Natl. Acad. Sci. U. S. A. 99, 15078\u201315083 (2002).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"22806_CR61","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/978-1-59745-000-3_24","volume":"322","author":"R Miledi","year":"2006","unstructured":"Miledi, R., Palma, E. & Eusebi, F. Microtransplantation of neurotransmitter receptors from cells to Xenopus oocyte membranes: New procedure for ion channel studies. Methods Mol. Biol. 322, 347\u2013355 (2006).","journal-title":"Methods Mol. Biol."},{"key":"22806_CR62","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/biomedicines10051075","volume":"10","author":"S Scalise","year":"2022","unstructured":"Scalise, S. et al. Human iPSC modeling of genetic febrile seizure reveals aberrant molecular and physiological features underlying an impaired neuronal activity. Biomedicines 10, 1075 (2022).","journal-title":"Biomedicines"},{"key":"22806_CR63","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/brainsci11040441","volume":"11","author":"P Cifelli","year":"2021","unstructured":"Cifelli, P. et al. Dissecting the molecular determinants of gabaa receptors current rundown, a hallmark of refractory human epilepsy. Brain Sci. 11, 441 (2021).","journal-title":"Brain Sci."},{"key":"22806_CR64","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nbd.2018.03.015","volume":"115","author":"G Ruffolo","year":"2018","unstructured":"Ruffolo, G. et al. A novel action of lacosamide on GABAA currents sets the ground for a synergic interaction with levetiracetam in treatment of epilepsy. Neurobiol. Dis. 115, 59\u201368 (2018).","journal-title":"Neurobiol. Dis."},{"key":"22806_CR65","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s11689-022-09416-2","volume":"14","author":"A Korotkov","year":"2022","unstructured":"Korotkov, A. et al. Down-regulation of the brain-specific cell-adhesion molecule contactin-3 in tuberous sclerosis complex during the early postnatal period. J. Neurodev. Disord. 14, 8 (2022).","journal-title":"J. Neurodev. Disord."},{"key":"22806_CR66","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/nan.12744","volume":"47","author":"V-E Gruber","year":"2021","unstructured":"Gruber, V.-E. et al. Impaired myelin production due to an intrinsic failure of oligodendrocytes in mTORpathies. Neuropathol. Appl. Neurobiol. 47, 812\u2013825 (2021).","journal-title":"Neuropathol. Appl. Neurobiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22806-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22806-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22806-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T16:11:21Z","timestamp":1701274281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22806-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["22806"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-22806-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"29 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17956"}}